BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20168060)

  • 21. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
    Kang JW; Kim JH; Ko GY; Gwon DI; Yoon HK; Sung KB
    Acta Radiol; 2012 Jun; 53(5):545-50. PubMed ID: 22547388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of solitary endobronchial metastasis of hepatocellular carcinoma].
    Kido T; Iwanaga T; Takata S; Kaketa Y; Kawanami T; Kido M
    Nihon Kokyuki Gakkai Zasshi; 2005 Jul; 43(7):422-6. PubMed ID: 16050469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
    Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
    Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial chemoembolization with gelatin sponge microparticles for barcelona clinic liver cancer Stage C and large hepatocellular carcinoma: Initial clinical experience.
    Zhou J; Liu Y; Ren Z; Zhang Y; Zhang M
    J Cancer Res Ther; 2017; 13(5):767-772. PubMed ID: 29237901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
    Takayasu K; Arii S; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M
    J Hepatol; 2012 Apr; 56(4):886-92. PubMed ID: 22173160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
    Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD
    World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous regression of a large hepatocellular carcinoma with skull metastasis.
    Nam SW; Han JY; Kim JI; Park SH; Cho SH; Han NI; Yang JM; Kim JK; Choi SW; Lee YS; Chung KW; Sun HS
    J Gastroenterol Hepatol; 2005 Mar; 20(3):488-92. PubMed ID: 15740500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relapse-Free Survival Following Multidisciplinary Therapy for Hepatocellular Carcinoma with Multiple Lung Metastases--A Case Report].
    Hasegawa H; Ueda S; Nakanoko T; Gion T; Kitamura M; Tanaka F
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1881-3. PubMed ID: 26805204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
    Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
    J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study.
    Song BC; Chung YH; Kim JA; Lee HC; Yoon HK; Sung KB; Yang SH; Yoo K; Lee YS; Suh DJ
    Cancer; 2001 Jun; 91(12):2386-93. PubMed ID: 11413529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim SH; Chung YH; Yang SH; Kim JA; Jang MK; Kim SE; Lee D; Lee SH; Lee D; Kim KM; Lim YS; Lee HC; Lee YS; Suh DJ
    Korean J Hepatol; 2009 Sep; 15(3):320-30. PubMed ID: 19783881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma.
    Lee SW; Lee HL; Han NI; Jang JW; Bae SH; Choi JY; Yoon SK
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):81-88. PubMed ID: 27913882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis.
    Hu Z; Huang P; Zhou Z; Li W; Xu J; Xu K; Wang J; Zhang H
    Clin Transl Oncol; 2018 Jun; 20(6):729-739. PubMed ID: 29110217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
    Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.